Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Oris Tandlægerne Tandlægehuset Assens I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   10.3% 8.8% 3.4% 7.7% 8.1% 8.7% 9.8% 9.8%   Credit score (0-100)   25 29 54 30 30 27 25 25   Credit rating   BB BB BBB BB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,943 11,811 11,776 13,260 14,001 14,502 0.0 0.0   EBITDA   6,395 6,878 1,863 6,057 6,190 6,269 0.0 0.0   EBIT   6,395 6,878 1,863 6,057 6,190 6,269 0.0 0.0   Pre-tax profit (PTP)   6,402.9 6,885.2 1,867.7 6,062.6 6,185.0 6,256.1 0.0 0.0   Net earnings   6,402.9 6,885.2 1,867.7 6,062.6 6,185.0 6,256.1 0.0 0.0   Pre-tax profit without non-rec. items   6,403 6,885 1,868 6,063 6,185 6,256 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   2,263 2,778 1,349 1,995 1,962 2,700 2,700 2,700   Interest-bearing liabilities   491 464 489 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,834 4,270 4,398 3,946 3,731 4,321 2,700 2,700   Net Debt   478 454 461 -27.4 -21.6 -40.7 -2,700 -2,700     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,943 11,811 11,776 13,260 14,001 14,502 0.0 0.0   Gross profit growth   14.7% 7.9% -0.3% 12.6% 5.6% 3.6% -100.0% 0.0%   Employees   12 12 18 16 17 15 0 0   Employee growth %   50.0% 0.0% 50.0% -11.1% 6.3% -11.8% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,834 4,270 4,398 3,946 3,731 4,321 2,700 2,700   Balance sheet change%   15.8% 11.4% 3.0% -10.3% -5.4% 15.8% -37.5% 0.0%   Added value   6,395.4 6,877.7 1,863.4 6,057.3 6,189.9 6,268.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   58.4% 58.2% 15.8% 45.7% 44.2% 43.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   179.2% 169.9% 43.1% 145.3% 161.4% 155.8% 0.0% 0.0%   ROI %   246.7% 229.6% 73.6% 316.4% 313.2% 269.2% 0.0% 0.0%   ROE %   296.4% 273.2% 90.5% 362.6% 312.6% 268.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   59.2% 65.5% 31.0% 51.1% 53.3% 62.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   7.5% 6.6% 24.7% -0.5% -0.3% -0.6% 0.0% 0.0%   Gearing %   21.7% 16.7% 36.2% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.3 3.0 1.5 2.4 2.6 3.4 0.0 0.0   Current Ratio   2.4 3.1 1.7 2.5 2.7 3.6 0.0 0.0   Cash and cash equivalent   13.5 10.5 27.7 27.4 21.6 40.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,263.3 2,882.9 1,742.5 2,388.6 2,364.7 3,120.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   533 573 104 379 364 418 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   533 573 104 379 364 418 0 0   EBIT / employee   533 573 104 379 364 418 0 0   Net earnings / employee   534 574 104 379 364 417 0 0